LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 14 of 15: Mean cell count and mean normalized growth rate inhibition values across all replicates. - Dataset (ID:20251)

 Full screen view
Filter results: >>>>
Cell Small Molecule Small Mol Concentration Small Mol Conc Unit LJP Library Plate Mean Relative Cell Count Standard Error of the Mean for Relative Cell Count Mean Normalized Growth Rate Inhibition Value Standard Error of the Mean for Normalized Growth Rate Inhibition Value
MCF7 XMD11-85h
0.37
uM
LJP6
 0.8762 0.0373 0.8575 0.0403
MCF7 XMD11-85h
1.11
uM
LJP6
 0.8366 0.0134 0.8075 0.0116
MCF7 XMD11-85h
3.33
uM
LJP6
 0.7961 0.0323 0.7576 0.0374
MCF7 XMD11-85h
10
uM
LJP6
 0.4624 0.0135 0.2983 0.0141
MCF7 XMD16-144
0.04
uM
LJP5
 0.3741 0.0149 0.1864 0.0206
MCF7 XMD16-144
0.12
uM
LJP5
 0.3511 0.0262 0.1474 0.0142
MCF7 XMD16-144
0.37
uM
LJP5
 0.3602 0.0329 0.1624 0.0338
MCF7 XMD16-144
1.11
uM
LJP5
 0.3619 0.0327 0.1654 0.0318
MCF7 XMD16-144
3.33
uM
LJP5
 0.3589 0.0289 0.1602 0.0322
MCF7 XMD16-144
10
uM
LJP5
 0.1521 0.0153 -0.2668 0.0052
MCF7 Erlotinib
0.04
uM
LJP5
 0.8717 0.0320 0.8585 0.0398
MCF7 Erlotinib
0.12
uM
LJP5
 0.9108 0.0357 0.8990 0.0430
MCF7 Erlotinib
0.37
uM
LJP5
 1.0236 0.0146 1.0236 0.0136
MCF7 Erlotinib
1.11
uM
LJP5
 1.0582 0.0307 1.0573 0.0270
MCF7 Erlotinib
3.33
uM
LJP5
 1.0379 0.0253 1.0367 0.0233
MCF7 Erlotinib
10
uM
LJP5
 0.9327 0.0375 0.9268 0.0429
MCF7 Gefitinib
0.04
uM
LJP6
 1.0839 0.0327 1.0913 0.0368
MCF7 Gefitinib
0.12
uM
LJP6
 1.0549 0.0348 1.0589 0.0397
MCF7 Gefitinib
0.37
uM
LJP6
 1.0502 0.0427 1.0529 0.0481
MCF7 Gefitinib
1.11
uM
LJP6
 1.0365 0.0471 1.0415 0.0532
MCF7 Gefitinib
3.33
uM
LJP6
 1.0256 0.0341 1.0278 0.0396
MCF7 Gefitinib
10
uM
LJP6
 0.8361 0.0152 0.8083 0.0229
MCF7 Nilotinib
0.04
uM
LJP5
 1.0276 0.0115 1.0284 0.0124
MCF7 Nilotinib
0.12
uM
LJP5
 1.0374 0.0216 1.0364 0.0218
MCF7 Nilotinib
0.37
uM
LJP5
 0.9729 0.0119 0.9709 0.0121